Prime Medicine stockholders elect directors, approve officer liability limitation

Prime Medicine, Inc.

Stockholders elected Wendy Chung, Kaye Foster, Keith Gottesdiener, and Jeffrey Marrazzo as Class II directors.
Approved certificate amendment to limit officer liability as permitted by Delaware law with 91.5M votes for.
Ratified PricewaterhouseCoopers as independent auditor for FY2024 with 106.9M votes for.
Annual meeting held June 12, 2024; quorum of 107.1M shares represented.
All proposals passed; no dissident activity or unexpected vote outcomes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.